Delivering High Quality HIV Prevention, Care and Treatment Services in The Bahamas under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH16 160902CONT17

Opportunity Information: Apply for CDC RFA GH16 160902CONT17

The grant opportunity titled "Delivering High Quality HIV Prevention, Care and Treatment Services in The Bahamas under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. government-funded public health award focused on supporting and sustaining HIV-related services in The Bahamas under the broader PEPFAR initiative. It is administered by the U.S. Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC), specifically within CDC's global health portfolio (CDC - CGH). The core purpose is to maintain and improve the quality and reach of HIV prevention, clinical care, and treatment activities, aligning with PEPFAR's emphasis on evidence-based programming, strong public health impact, and measurable outcomes along the HIV service continuum, from prevention and testing through treatment initiation and long-term viral suppression.

This funding notice is identified as a continuation opportunity, meaning it is intended to support ongoing work rather than launch an entirely new, open competition for first-time applicants. The instrument type is a cooperative agreement, which generally indicates an arrangement where CDC expects to have substantial involvement in the funded activities. In practice, that typically means the recipient carries out day-to-day implementation, while CDC provides technical guidance, program oversight, collaboration on strategy, and support for monitoring, evaluation, and quality improvement. The activity category is Health, and it is associated with CFDA number 93.067, which corresponds to CDC's global HIV/AIDS efforts and related public health assistance.

The opportunity number is CDC RFA GH16-160902CONT17, and it was created on February 6, 2017, with an original closing date of April 6, 2017. The notice lists an expected 10 awards, suggesting CDC anticipated funding multiple implementing partners or multiple continuation recipients supporting different facets of the HIV response in-country, such as prevention programming, clinical service delivery support, laboratory and surveillance strengthening, data systems, and workforce or quality management initiatives. The award ceiling is shown as 0 in the source data, which commonly reflects that a single fixed maximum award amount was not specified in the summary fields and that actual funding levels would be determined by CDC based on the continuation scope, available appropriations, and approved budgets and work plans.

Eligibility is described broadly as "Others," with further clarification referenced in an additional eligibility text field (not included in the provided excerpt). In many CDC continuation announcements, eligibility is often limited to existing recipients or specific categories of organizations already engaged in the project, rather than open to all entities. That said, the listing itself does not provide the detailed eligibility restrictions, so any organization considering this type of opportunity would normally need to review the full announcement text to confirm whether it is limited to current awardees, certain partner types, or entities meeting specific in-country operational requirements.

Overall, this opportunity is designed to advance PEPFAR-supported HIV outcomes in The Bahamas by ensuring high-quality prevention services, strengthening HIV care systems, and supporting effective antiretroviral treatment delivery and retention. It sits within CDC's role in PEPFAR, which typically includes supporting national HIV programs through technical assistance, surveillance and strategic information, implementation science and evaluation, and quality improvement approaches that help programs identify gaps and improve performance over time.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Delivering High Quality HIV Prevention, Care and Treatment Services in The Bahamas under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 06, 2017.
• Applicants must submit their applications by Apr 06, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 160902CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: